Endocrine Drugs Flashcards
1
Q
Acromegaly
A
Too much growth hormone (GH)
- somatostatins (GH inhibitor)
- Ocreotide (50% success)
- Pegvisomant (95% success)
2
Q
Achondroplasia
A
too little growth hormone
- HGH 20-24mg/kg/week
3
Q
Hyperprolactinemia
A
too much prolactin
- dopamine analogs (dopamine inhibits prolactin)
- Cabergoline 0.25mcg PO bid
4
Q
Diabetes Insipidus
A
too little ADH (central) or kidneys insensitive (nephrogenic)
- Desmopressin 5mcg IM at bedtime then 5-20mcg 1-2x daily
5
Q
Hypogonadism
A
too little GnRH (decr. LH/FSH)
- testosterone
- Androderm 2-6mg/d transdermal
- Androgel 20-81mg/d metered pump
- Depo-testosterone 100-200mg IM q2w
6
Q
Adrenal Insufficiency
A
too little cortisol
(Addison’s - autoimmune destruction of adrenal cortex)
- replace cortisol
- Hydrocortisone 15-25mg PO qd/bid (x3 if illness)
- replace aldosterone (not needed if 2’ adrenal insufficiency)
- Fludrocortisone 0.1-0.15mg PO qd
7
Q
Adrenal Crisis
A
- IV saline for volume depletion
- IV hydrocortisone succinate 100mg STAT
- parental hydrocortisone 50-100mg IM q6h until can tolerate oral therapy
- 10% glucose IV for hypoglycemia
8
Q
Adrenal Overproduction
A
too much cortisol
(Cushing’s)
- tumor/adrenal removal
- corticrope therapy- Cabergoline
9
Q
Primary Hyperaldosteronism
A
too much aldosterone
(uncontrolled HBP)
- adenoma
- adrenalectomy
- idiopathic
- Spirolactone 12-25mg PO qd
10
Q
Pheochromocytomas
A
adrenal medulla tumor
(too high catecholamines: adrenaline, noradrenaline, dopamine)
- tumor removal
11
Q
Hypothyroidism
A
too little T3/T4 (1’) or TSH (2’)
- Synthroid LT4 1.6mg/kg/day then increase by 25mcg until TSH levels 1-2.5 U/L
12
Q
Hyperthyroidism
A
too high T3/T4
- Atenolol (beta-blocker) 25-50mg PO up to 200mg in 2 divided doses qd to get HR <90
- Thionamides (anti-thyroid drug)
- Methimazole 10mg PO qd (d/c if agranulocytosis)
- thyroidectomy or radioiodine 131 (unless pregnant, nursing, active Grave’s opthalmopathy)
13
Q
Type I Diabetes
A
- insulin
14
Q
Type II Diabetes
A
- metformin
- affects liver mitochondria: produces less glucose, improves insulin sensitivity, reduces appetite
- contraindicated with eGFR < 30, acidosis, hypoxia, dehydration/volume depletion, radiocontrast
- sulfonylureas
- beta cell stimulators
- Glimepiride, Glyburide, Glipizide
- “glinides” - shorter acting
- Repaglinide, Nateglinide
- TZDs
- reduce insulin resistance
- Pioglitazone, Rosiglitazone
- incretins (GLP-1 receptor agonists)
- stimulate insulin in response to oral glucose
- Exenatide, Liraglutide, Dulaglutide
- gliptins (GPP-4 inhibitors)
- block GLP-1/GIP deactivators
- Canagliflozin, Dapagliflozin, Empagliflozin
15
Q
DKA
A
- ABC
- admit to ICU
- Normal saline 500-1000ml/h then 250-500/h in 2-4h
- replenish K+ to 3.3-5.3
- hold insulin until >3.3
- insulin
- low dose IV .1 U/kg bolus
- infuse at .1 U/kg/h
- when glucose ~200 in DKA or 250-300 in HHS: D5 saline w/ KCl
- IV bicarb if pH <6.9